Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.13 - $3.69 $40,238 - $131,397
-35,609 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$2.85 - $3.73 $66,955 - $87,628
23,493 Added 193.9%
35,609 $117,000
Q4 2021

Feb 11, 2022

SELL
$3.24 - $5.18 $591,863 - $946,251
-182,674 Reduced 93.78%
12,116 $41,000
Q3 2021

Nov 18, 2021

BUY
$3.94 - $5.84 $767,472 - $1.14 Million
194,790 New
194,790 $993,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $202M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.